CAMO PARTNERS

CURRENT ONCOLOGY

Current Oncology (ISSN 1718-7729) is an international, peer-reviewed, open access journal published online by MDPI (from Volume 28 Issue 1-2021). Established in 1994, the journal represents a multidisciplinary medium for clinical oncologists to report and review progress in the management of this disease. Dr. Shahid Ahmed from the University of Saskatchewan has served as Editor-in-Chief of Current Oncology since June 2023. The journal is supported by an international editorial board consisting of a distinguished team of cancer researchers from major institutes from Canada and around the world (http://www.mdpi.com/journal/curroncol/editors). Articles published in the journal typically contain information that is relevant directly to clinical oncology practice, and have clear potential for application to the current or future practice of cancer medicine. Current Oncology is indexed by important databases, including SCIE, PubMed, MEDLINE, and Scopus. Current Oncology received an increased Impact Factor for 2023 of 2.8, following an increased CiteScore of 3.3. Current Oncology now ranks in Q2 in the “Oncology” category (157/322) which represents our ranking relative to other journals in the same field. More information about the journal can be accessed at: http://www.mdpi.com/journal/curroncol.



CAMO members enjoy author fee discounts with Current Oncology. Please contact the CAMO Office for the discount code or email Karen (karen.irwin@mdpi.com) when submitting your paper, to let her know to apply the discount.



NOTE:  When you apply for research funding, please inquire whether your granting agency allows the costs of open access publishing, such as Article Processing Charges, to be included in the grant budget.  More and more, granting agencies are encouraging or even requiring that all papers resulting from funded research must be published in Open Access journals.

More information about the journal can be accessed here.